Robust research: Institutions must do their part for reproducibility

C. Glenn Begley (), Alastair M. Buchan and Ulrich Dirnagl
Additional contact information
C. Glenn Begley: C. Glenn Begley is chief scientific officer at TetraLogic Pharmaceuticals, Malvern, Pennsylvania, USA.
Alastair M. Buchan: Oxford NIHR Biomedical Research Centre, University of Oxford, UK.
Ulrich Dirnagl: Ulrich Dirnagl is director of the Center for Stroke Research at the Universitätsmedizin Charité Berlin, Germany.

Nature, 2015, vol. 525, issue 7567, 25-27

Abstract: Tie funding to verified good institutional practice, and robust science will shoot up the agenda, say C. Glenn Begley, Alastair M. Buchan and Ulrich Dirnagl.

Date: 2015
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.nature.com/articles/525025a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:525:y:2015:i:7567:d:10.1038_525025a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/525025a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().